Test Bank Complete_
Pharmacotherapy: A Pathophysiologic Approach 10th Edition,
By Joseph Dipiro & 5 More
All Chapters 1-144| 18 Units| Latest Version With Verified And Detailed Answers
,SECTION 1: FOUNDATION ISSUES ________________________________________________ 8
Chapter 1: Health Literacy And Medication Use __________________________________________ 8
Chapter 2: Cultural Competency _____________________________________________________ 19
Chapter 3: Medication Safety Principles And Practices ___________________________________ 28
Chapter 4: Clinical Pharmacokinetics And Pharmacodynamics _____________________________ 39
Chapter 5: Pharmacogenetics _______________________________________________________ 47
Chapter 6: Pediatrics ______________________________________________________________ 55
Chapter 7: Geriatrics ______________________________________________________________ 67
Chapter 8: Palliative Care ___________________________________________________________ 76
Chapter 9: Clinical Toxicology _______________________________________________________ 86
Chapter 10: Clinical Management Of Potential Bioterrorism-Related Conditions ______________ 94
SECTION 2: CARDIOVASCULAR DISORDERS _______________________________________ 102
Chapter 11: Cardiovascular Testing __________________________________________________ 102
Chapter 12: Cardiac Arrest _________________________________________________________ 104
Chapter 13: Hypertension _________________________________________________________ 109
Chapter 14: Chronic Heart Failure ___________________________________________________ 118
Chapter 15: Acute Decompensated Heart Failure ______________________________________ 123
Chapter 16: Stable Ischemic Heart Disease ____________________________________________ 130
Chapter 17: Acute Coronary Syndromes ______________________________________________ 137
Chapter 18: The Arrhythmias _______________________________________________________ 146
Chapter 19: Venous Thromboembolism ______________________________________________ 149
Chapter 20: Stroke _______________________________________________________________ 154
Chapter 21: Dyslipidemia __________________________________________________________ 162
Chapter 22: Peripheral Arterial Disease ______________________________________________ 166
Chapter 23: Use Of Vasopressors And Inotropes In The Pharmacotherapy Of Shock ___________ 172
Chapter 24: Hypovolemic Shock ____________________________________________________ 177
Chapter 25: Introduction To Pulmonary Function Testing ________________________________ 183
SECTION 3: RESPIRATORY DISORDERS___________________________________________ 188
Chapter 26: Asthma ______________________________________________________________ 188
Chapter 27: Chronic Obstructive Pulmonary Disease ____________________________________ 192
Chapter 28: Pulmonary Arterial Hypertension _________________________________________ 197
, Chapter 29: Cystic Fibrosis _________________________________________________________ 200
Chapter 30: Drug-Induced Pulmonary Diseases ________________________________________ 203
SECTION 4: GASTROINTESTINAL DISORDERS _____________________________________ 207
Chapter 31: Evaluation Of The Gastrointestinal Tract ___________________________________ 207
Chapter 32: Gastroesophageal Reflux Disease _________________________________________ 211
Chapter 33: Peptic Ulcer Disease And Related Disorders _________________________________ 216
Chapter 34: Inflammatory Bowel Disease _____________________________________________ 220
Chapter 35: Nausea And Vomiting __________________________________________________ 224
Chapter 36: Diarrhea, Constipation, And Irritable Bowel Syndrome ________________________ 228
Chapter 37: Portal Hypertension And Cirrhosis ________________________________________ 234
Chapter 38: Drug-Induced Liver Disease ______________________________________________ 238
Chapter 39: Pancreatitis ___________________________________________________________ 241
Chapter 40: Viral Hepatitis _________________________________________________________ 245
Chapter 41: Celiac Disease _________________________________________________________ 250
SECTION 5: RENAL DISORDERS_________________________________________________ 254
Chapter 42: Evaluation Of Kidney Function ___________________________________________ 254
Chapter 43: Acute Kidney Injury ____________________________________________________ 259
Chapter 44: Chronic Kidney Disease _________________________________________________ 265
Chapter 45: Hemodialysis And Peritoneal Dialysis ______________________________________ 270
Chapter 46: Drug-Induced Kidney Disease ____________________________________________ 275
Chapter 47: Glomerulonephritis ____________________________________________________ 279
Chapter 48: Drug Therapy Individualization For Patients With Chronic Kidney Disease ________ 283
Chapter 49: Disorders Of Sodium And Water Homeostasis _______________________________ 288
Chapter 50: Disorders Of Calcium And Phosphorus Homeostasis __________________________ 293
Chapter 51: Disorders Of Potassium And Magnesium Homeostasis ________________________ 298
Chapter 52: Acid–Base Disorders ____________________________________________________ 302
SECTION 6: NEUROLOGIC DISORDERS ___________________________________________ 310
Chapter 53: Evaluation Of Neurologic Illness __________________________________________ 310
Chapter 54: Alzheimer Disease _____________________________________________________ 314
Chapter 55: Multiple Sclerosis ______________________________________________________ 319
Chapter 56: Epilepsy______________________________________________________________ 324
, Chapter 57: Status Epilepticus ______________________________________________________ 328
Chapter 58: Acute Management Of The Brain Injury Patient ______________________________ 332
Chapter 59: Parkinson Disease _____________________________________________________ 336
Chapter 60: Pain Management _____________________________________________________ 340
Chapter 61: Headache Disorders ____________________________________________________ 344
SECTION 7: PSYCHIATRIC DISORDERS ___________________________________________ 348
Chapter 62: Assessment Of Psychiatric Disorders_______________________________________ 348
Chapter 63: Attention Deficit/Hyperactivity Disorder ___________________________________ 354
Chapter 64: Eating Disorders _______________________________________________________ 359
Chapter 65: Substance-Related Disorders I: Overview And Depressants, Stimulants, And
Hallucinogens ___________________________________________________________________ 364
Chapter 66: Substance-Related Disorders Ii: Alcohol, Nicotine, And Caffeine ________________ 369
Chapter 67: Schizophrenia _________________________________________________________ 374
Chapter 68: Major Depressive Disorder ______________________________________________ 380
Chapter 69: Bipolar Disorder _______________________________________________________ 384
Chapter 70: Anxiety Disorders: Generalized Anxiety, Panic, And Social Anxiety Disorders ______ 388
Chapter 71: Posttraumatic Stress Disorder And Obsessive-Compulsive Disorder______________ 393
Chapter 72: Sleep–Wake Disorders __________________________________________________ 398
Chapter 73: Disorders Associated With Intellectual Disabilities ___________________________ 402
SECTION 8: ENDOCRINOLOGIC DISORDERS _______________________________________ 407
Chapter 74: Diabetes Mellitus ______________________________________________________ 407
Chapter 75: Thyroid Disorders ______________________________________________________ 414
Chapter 76: Adrenal Gland Disorders ________________________________________________ 419
Chapter 77: Pituitary Gland Disorders ________________________________________________ 422
SECTION 9: GYNECOLOGIC AND OBSTETRIC DISORDERS ____________________________ 426
Chapter 78: Pregnancy And Lactation: Therapeutic Considerations ________________________ 426
Chapter 79: Contraception _________________________________________________________ 431
Chapter 80: Menstruation-Related Disorders __________________________________________ 437
Chapter 81: Endometriosis _________________________________________________________ 442
Chapter 82: Hormone Therapy In Women ____________________________________________ 447
SECTION 10: UROLOGIC DISORDERS ____________________________________________ 451
Chapter 83: Erectile Dysfunction ____________________________________________________ 451
, Chapter 84: Benign Prostatic Hyperplasia _____________________________________________ 456
Chapter 85: Urinary Incontinence ___________________________________________________ 461
SECTION 11: IMMUNOLOGIC DISORDERS ________________________________________ 465
Chapter 86: Function And Evaluation Of The Immune System ____________________________ 465
Chapter 87: Systemic Lupus Erythematosus ___________________________________________ 477
Chapter 88: Drug Allergy __________________________________________________________ 481
Chapter 89: Solid-Organ Transplantation _____________________________________________ 484
SECTION 12: RHEUMATOLOGIC DISORDERS ______________________________________ 489
Chapter 90: Osteoarthritis _________________________________________________________ 489
Chapter 91: Rheumatoid Arthritis ___________________________________________________ 494
Chapter 92: Osteoporosis And Osteomalacia __________________________________________ 499
Chapter 93: Gout And Hyperuricemia ________________________________________________ 504
SECTION 13: OPHTHALMIC AND OTOLARYNGOLOGICAL DISORDERS __________________ 505
Chapter 94: Glaucoma ____________________________________________________________ 505
Chapter 95: Allergic Rhinitis ________________________________________________________ 516
SECTION 14: DERMATOLOGIC DISORDERS _______________________________________ 521
Chapter 96: Acne Vulgaris _________________________________________________________ 521
Chapter 97: Psoriasis _____________________________________________________________ 524
Chapter 98: Atopic Dermatitis ______________________________________________________ 526
Chapter 99: Dermatologic Drug Reactions And Common Skin Conditions ___________________ 528
SECTION 15: HEMATOLOGIC DISORDERS ________________________________________ 538
Chapter 100: Anemias ____________________________________________________________ 538
Chapter 101: Coagulation Disorders _________________________________________________ 552
Chapter 102: Sickle Cell Disease ____________________________________________________ 556
Chapter 103: Drug-Induced Hematologic Disorders _____________________________________ 560
SECTION 16: INFECTIOUS DISEASES _____________________________________________ 564
Chapter 104: Laboratory Tests To Direct Antimicrobial Pharmacotherapy ___________________ 564
Chapter 105: Antimicrobial Regimen Selection ________________________________________ 570
Chapter 106: Central Nervous System Infections _______________________________________ 582
Chapter 107: Lower Respiratory Tract Infections _______________________________________ 586
Chapter 108: Upper Respiratory Tract Infections _______________________________________ 596
, Chapter 109: Influenza ____________________________________________________________ 600
Chapter 110: Skin And Soft-Tissue Infections __________________________________________ 605
Chapter 111: Infective Endocarditis__________________________________________________ 611
Chapter 112: Tuberculosis _________________________________________________________ 616
Chapter 113: Gastrointestinal Infections And Enterotoxigenic Poisonings ___________________ 622
Chapter 114: Intra-Abdominal Infections _____________________________________________ 627
Chapter 115: Parasitic Diseases _________________________________________________ 631
Chapter 116: Urinary Tract Infections And Prostatitis ___________________________________ 640
Chapter 117: Sexually Transmitted Diseases __________________________________________ 645
Chapter 118: Bone And Joint Infections ______________________________________________ 664
Chapter 119: Sepsis And Septic Shock ________________________________________________ 668
Chapter 120: Superficial Fungal Infections ____________________________________________ 672
Chapter 121: Invasive Fungal Infections ______________________________________________ 676
Chapter 122: Infections In Immunocompromised Patients _______________________________ 683
Chapter 123: Antimicrobial Prophylaxis In Surgery _____________________________________ 688
Chapter 124: Travel Health ________________________________________________________ 692
Chapter 125: Vaccines And Immunoglobulins__________________________________________ 696
Chapter 126: Human Immunodeficiency Virus Infection _________________________________ 701
SECTION 17: ONCOLOGIC DISORDERS ___________________________________________ 706
Chapter 127: Cancer Treatment And Chemotherapy ____________________________________ 706
Chapter 128: Breast Cancer ________________________________________________________ 711
Chapter 129: Lung Cancer _________________________________________________________ 716
Chapter 130: Colorectal Cancer _____________________________________________________ 717
Chapter 131: Prostate Cancer ______________________________________________________ 723
Chapter 132: Lymphomas _________________________________________________________ 724
Chapter 133: Ovarian Cancer _______________________________________________________ 726
Chapter 134: Acute Leukemias _____________________________________________________ 734
Chapter 135: Chronic Leukemias ____________________________________________________ 739
Chapter 136: Multiple Myeloma ____________________________________________________ 742
Chapter 137: Myelodysplastic Syndromes ____________________________________________ 746
Chapter 138: Renal Cell Carcinoma __________________________________________________ 751
, Chapter 139: Melanoma __________________________________________________________ 760
Chapter 140: Hematopoietic Stem Cell Transplantation _________________________________ 767
SECTION 18: NUTRITIONAL DISORDERS _________________________________________ 779
Chapter 141: Assessment Of Nutrition Status And Nutrition Requirements __________________ 779
Chapter 142: Parenteral Nutrition ___________________________________________________ 784
Chapter 143: Enteral Nutrition _____________________________________________________ 795
Chapter 144: Obesity _____________________________________________________________ 799
,SECTION 1: FOUNDATION ISSUES
Chapter 1: Health Literacy And Medication Use
Joseph DiPiro: Pharmacotherapy: A Pathophysiologic Approach 10th Edition| Tenth Edition
MULTIPLE CHOICE
1. What Time Will The Trough Blood Level Need To Be Drawn If The Nurse
Administers The Intravenous Medication Dose At 9:00 Am?
A. 6:30 Am
B. 8:30 Am
C. 9:30 Am
D. 11:30 Am
CORRECT ANS: B
Trough Blood Levels Measure The Lowest Blood Level Of Medicine And Are
Obtained Just Before The Dose Is Administered. In This Case, 6:30 Am Is
Too Early To Obtain The Blood Level. The Other Two Times Occur After The
Medication Is Administered.
A. 6:30 Am Is Too Early As It Is Well Before The Scheduled Dose.
C. 9:30 Am And D. 11:30 Am Are Both After The Dose Has Been
Administered, So They Are Not Appropriate Times For The Trough Blood
Level.
2. What Will The Nurse Expect The Health Care Providers Order To Be
When Starting An Older Adult Patient On Thyroid Hormone Replacement
Therapy?
A. Administering A Loading Dose Of The Drug
,B. Directions On How To Taper The Drug
C. A Dosage That Is One Third To One Half Of The Regular Dosage
D. A Dosage That Is Double The Regular Dosage
CORRECT ANS: C
To Prevent Toxicity, Dosages For New Medications In Older Adults Should
Be One Third To One Half The Amount Of A Standard Adult Dosage.
Loading Doses Of Drugs Could Cause Severe Toxicity. Tapering Off Is
Characteristic Of Discontinuation Of Medications And Is Not Appropriate
For This Situation. Older Adults Generally Need A Lower Medication Dosage
Than Younger Patients.
A. Administering A Loading Dose Could Cause Toxicity, Which Is Not
Recommended For Older Adults.
B. Directions On How To Taper The Drug Are Used For Discontinuation Of
Medication, Not For Initiation.
D. A Dosage That Is Double The Regular Dosage Would Be Dangerous,
Especially For Older Adults Who Have A Slower Metabolism.
Dif: Cognitive Level: Application Ref: P. 29 Obj: 3 Top: Nursing Process Step:
Implementation
Msc: Nclex Client Needs Category: Physiological Integrity
3. Which Drugs Cause Birth Defects?
A. Teratogens
B. Carcinogens
C. Metabolites
D. Placebos CORRECT ANS: A
Teratogens Are Drugs That Cause Birth Defects. Carcinogens Cause Cancer.
Metabolites Are The End Product Of Metabolism. Placebos Are Drugs That
Have No Pharmacologic Activity.
, B. Carcinogens Cause Cancer, Not Birth Defects.
C. Metabolites Are The Byproducts Of Metabolism, Not Drugs That Cause
Birth Defects.
D. Placebos Are Inactive Substances That Do Not Have Any Pharmacologic
Effects, Including Birth Defects.
4. Which Life-Threatening Illness May Occur As A Result Of Aspirin
(Salicylate) Administration During Viral Illness To Patients Younger Than
20 Years Of Age?
A. Anaphylactic Shock
B. Reyes Syndrome
C. Chickenpox
D. Influenza A
CORRECT ANS: B
Children Are Susceptible To Reyes Syndrome If They Ingest Aspirin At The
Time Of Or Shortly After A Viral Infection Of Chickenpox Or Influenza.
Anaphylactic Shock Is Caused By A Hypersensitivity Reaction. Chickenpox Is
The Result Of Being Infected With A Virus. Influenza A Is Caused By A
Pathogen.
A. Anaphylactic Shock Is An Allergic Reaction, Not A Consequence Of
Aspirin Use During A Viral Illness.
C. Chickenpox Is Caused By A Viral Infection But Is Not Related To Aspirin
Administration.
D. Influenza A Is Caused By A Virus, Not Directly By Aspirin Use.
5. Which Classification Of Medications Commonly Causes Allergic Reactions
In Children?
Pharmacotherapy: A Pathophysiologic Approach 10th Edition,
By Joseph Dipiro & 5 More
All Chapters 1-144| 18 Units| Latest Version With Verified And Detailed Answers
,SECTION 1: FOUNDATION ISSUES ________________________________________________ 8
Chapter 1: Health Literacy And Medication Use __________________________________________ 8
Chapter 2: Cultural Competency _____________________________________________________ 19
Chapter 3: Medication Safety Principles And Practices ___________________________________ 28
Chapter 4: Clinical Pharmacokinetics And Pharmacodynamics _____________________________ 39
Chapter 5: Pharmacogenetics _______________________________________________________ 47
Chapter 6: Pediatrics ______________________________________________________________ 55
Chapter 7: Geriatrics ______________________________________________________________ 67
Chapter 8: Palliative Care ___________________________________________________________ 76
Chapter 9: Clinical Toxicology _______________________________________________________ 86
Chapter 10: Clinical Management Of Potential Bioterrorism-Related Conditions ______________ 94
SECTION 2: CARDIOVASCULAR DISORDERS _______________________________________ 102
Chapter 11: Cardiovascular Testing __________________________________________________ 102
Chapter 12: Cardiac Arrest _________________________________________________________ 104
Chapter 13: Hypertension _________________________________________________________ 109
Chapter 14: Chronic Heart Failure ___________________________________________________ 118
Chapter 15: Acute Decompensated Heart Failure ______________________________________ 123
Chapter 16: Stable Ischemic Heart Disease ____________________________________________ 130
Chapter 17: Acute Coronary Syndromes ______________________________________________ 137
Chapter 18: The Arrhythmias _______________________________________________________ 146
Chapter 19: Venous Thromboembolism ______________________________________________ 149
Chapter 20: Stroke _______________________________________________________________ 154
Chapter 21: Dyslipidemia __________________________________________________________ 162
Chapter 22: Peripheral Arterial Disease ______________________________________________ 166
Chapter 23: Use Of Vasopressors And Inotropes In The Pharmacotherapy Of Shock ___________ 172
Chapter 24: Hypovolemic Shock ____________________________________________________ 177
Chapter 25: Introduction To Pulmonary Function Testing ________________________________ 183
SECTION 3: RESPIRATORY DISORDERS___________________________________________ 188
Chapter 26: Asthma ______________________________________________________________ 188
Chapter 27: Chronic Obstructive Pulmonary Disease ____________________________________ 192
Chapter 28: Pulmonary Arterial Hypertension _________________________________________ 197
, Chapter 29: Cystic Fibrosis _________________________________________________________ 200
Chapter 30: Drug-Induced Pulmonary Diseases ________________________________________ 203
SECTION 4: GASTROINTESTINAL DISORDERS _____________________________________ 207
Chapter 31: Evaluation Of The Gastrointestinal Tract ___________________________________ 207
Chapter 32: Gastroesophageal Reflux Disease _________________________________________ 211
Chapter 33: Peptic Ulcer Disease And Related Disorders _________________________________ 216
Chapter 34: Inflammatory Bowel Disease _____________________________________________ 220
Chapter 35: Nausea And Vomiting __________________________________________________ 224
Chapter 36: Diarrhea, Constipation, And Irritable Bowel Syndrome ________________________ 228
Chapter 37: Portal Hypertension And Cirrhosis ________________________________________ 234
Chapter 38: Drug-Induced Liver Disease ______________________________________________ 238
Chapter 39: Pancreatitis ___________________________________________________________ 241
Chapter 40: Viral Hepatitis _________________________________________________________ 245
Chapter 41: Celiac Disease _________________________________________________________ 250
SECTION 5: RENAL DISORDERS_________________________________________________ 254
Chapter 42: Evaluation Of Kidney Function ___________________________________________ 254
Chapter 43: Acute Kidney Injury ____________________________________________________ 259
Chapter 44: Chronic Kidney Disease _________________________________________________ 265
Chapter 45: Hemodialysis And Peritoneal Dialysis ______________________________________ 270
Chapter 46: Drug-Induced Kidney Disease ____________________________________________ 275
Chapter 47: Glomerulonephritis ____________________________________________________ 279
Chapter 48: Drug Therapy Individualization For Patients With Chronic Kidney Disease ________ 283
Chapter 49: Disorders Of Sodium And Water Homeostasis _______________________________ 288
Chapter 50: Disorders Of Calcium And Phosphorus Homeostasis __________________________ 293
Chapter 51: Disorders Of Potassium And Magnesium Homeostasis ________________________ 298
Chapter 52: Acid–Base Disorders ____________________________________________________ 302
SECTION 6: NEUROLOGIC DISORDERS ___________________________________________ 310
Chapter 53: Evaluation Of Neurologic Illness __________________________________________ 310
Chapter 54: Alzheimer Disease _____________________________________________________ 314
Chapter 55: Multiple Sclerosis ______________________________________________________ 319
Chapter 56: Epilepsy______________________________________________________________ 324
, Chapter 57: Status Epilepticus ______________________________________________________ 328
Chapter 58: Acute Management Of The Brain Injury Patient ______________________________ 332
Chapter 59: Parkinson Disease _____________________________________________________ 336
Chapter 60: Pain Management _____________________________________________________ 340
Chapter 61: Headache Disorders ____________________________________________________ 344
SECTION 7: PSYCHIATRIC DISORDERS ___________________________________________ 348
Chapter 62: Assessment Of Psychiatric Disorders_______________________________________ 348
Chapter 63: Attention Deficit/Hyperactivity Disorder ___________________________________ 354
Chapter 64: Eating Disorders _______________________________________________________ 359
Chapter 65: Substance-Related Disorders I: Overview And Depressants, Stimulants, And
Hallucinogens ___________________________________________________________________ 364
Chapter 66: Substance-Related Disorders Ii: Alcohol, Nicotine, And Caffeine ________________ 369
Chapter 67: Schizophrenia _________________________________________________________ 374
Chapter 68: Major Depressive Disorder ______________________________________________ 380
Chapter 69: Bipolar Disorder _______________________________________________________ 384
Chapter 70: Anxiety Disorders: Generalized Anxiety, Panic, And Social Anxiety Disorders ______ 388
Chapter 71: Posttraumatic Stress Disorder And Obsessive-Compulsive Disorder______________ 393
Chapter 72: Sleep–Wake Disorders __________________________________________________ 398
Chapter 73: Disorders Associated With Intellectual Disabilities ___________________________ 402
SECTION 8: ENDOCRINOLOGIC DISORDERS _______________________________________ 407
Chapter 74: Diabetes Mellitus ______________________________________________________ 407
Chapter 75: Thyroid Disorders ______________________________________________________ 414
Chapter 76: Adrenal Gland Disorders ________________________________________________ 419
Chapter 77: Pituitary Gland Disorders ________________________________________________ 422
SECTION 9: GYNECOLOGIC AND OBSTETRIC DISORDERS ____________________________ 426
Chapter 78: Pregnancy And Lactation: Therapeutic Considerations ________________________ 426
Chapter 79: Contraception _________________________________________________________ 431
Chapter 80: Menstruation-Related Disorders __________________________________________ 437
Chapter 81: Endometriosis _________________________________________________________ 442
Chapter 82: Hormone Therapy In Women ____________________________________________ 447
SECTION 10: UROLOGIC DISORDERS ____________________________________________ 451
Chapter 83: Erectile Dysfunction ____________________________________________________ 451
, Chapter 84: Benign Prostatic Hyperplasia _____________________________________________ 456
Chapter 85: Urinary Incontinence ___________________________________________________ 461
SECTION 11: IMMUNOLOGIC DISORDERS ________________________________________ 465
Chapter 86: Function And Evaluation Of The Immune System ____________________________ 465
Chapter 87: Systemic Lupus Erythematosus ___________________________________________ 477
Chapter 88: Drug Allergy __________________________________________________________ 481
Chapter 89: Solid-Organ Transplantation _____________________________________________ 484
SECTION 12: RHEUMATOLOGIC DISORDERS ______________________________________ 489
Chapter 90: Osteoarthritis _________________________________________________________ 489
Chapter 91: Rheumatoid Arthritis ___________________________________________________ 494
Chapter 92: Osteoporosis And Osteomalacia __________________________________________ 499
Chapter 93: Gout And Hyperuricemia ________________________________________________ 504
SECTION 13: OPHTHALMIC AND OTOLARYNGOLOGICAL DISORDERS __________________ 505
Chapter 94: Glaucoma ____________________________________________________________ 505
Chapter 95: Allergic Rhinitis ________________________________________________________ 516
SECTION 14: DERMATOLOGIC DISORDERS _______________________________________ 521
Chapter 96: Acne Vulgaris _________________________________________________________ 521
Chapter 97: Psoriasis _____________________________________________________________ 524
Chapter 98: Atopic Dermatitis ______________________________________________________ 526
Chapter 99: Dermatologic Drug Reactions And Common Skin Conditions ___________________ 528
SECTION 15: HEMATOLOGIC DISORDERS ________________________________________ 538
Chapter 100: Anemias ____________________________________________________________ 538
Chapter 101: Coagulation Disorders _________________________________________________ 552
Chapter 102: Sickle Cell Disease ____________________________________________________ 556
Chapter 103: Drug-Induced Hematologic Disorders _____________________________________ 560
SECTION 16: INFECTIOUS DISEASES _____________________________________________ 564
Chapter 104: Laboratory Tests To Direct Antimicrobial Pharmacotherapy ___________________ 564
Chapter 105: Antimicrobial Regimen Selection ________________________________________ 570
Chapter 106: Central Nervous System Infections _______________________________________ 582
Chapter 107: Lower Respiratory Tract Infections _______________________________________ 586
Chapter 108: Upper Respiratory Tract Infections _______________________________________ 596
, Chapter 109: Influenza ____________________________________________________________ 600
Chapter 110: Skin And Soft-Tissue Infections __________________________________________ 605
Chapter 111: Infective Endocarditis__________________________________________________ 611
Chapter 112: Tuberculosis _________________________________________________________ 616
Chapter 113: Gastrointestinal Infections And Enterotoxigenic Poisonings ___________________ 622
Chapter 114: Intra-Abdominal Infections _____________________________________________ 627
Chapter 115: Parasitic Diseases _________________________________________________ 631
Chapter 116: Urinary Tract Infections And Prostatitis ___________________________________ 640
Chapter 117: Sexually Transmitted Diseases __________________________________________ 645
Chapter 118: Bone And Joint Infections ______________________________________________ 664
Chapter 119: Sepsis And Septic Shock ________________________________________________ 668
Chapter 120: Superficial Fungal Infections ____________________________________________ 672
Chapter 121: Invasive Fungal Infections ______________________________________________ 676
Chapter 122: Infections In Immunocompromised Patients _______________________________ 683
Chapter 123: Antimicrobial Prophylaxis In Surgery _____________________________________ 688
Chapter 124: Travel Health ________________________________________________________ 692
Chapter 125: Vaccines And Immunoglobulins__________________________________________ 696
Chapter 126: Human Immunodeficiency Virus Infection _________________________________ 701
SECTION 17: ONCOLOGIC DISORDERS ___________________________________________ 706
Chapter 127: Cancer Treatment And Chemotherapy ____________________________________ 706
Chapter 128: Breast Cancer ________________________________________________________ 711
Chapter 129: Lung Cancer _________________________________________________________ 716
Chapter 130: Colorectal Cancer _____________________________________________________ 717
Chapter 131: Prostate Cancer ______________________________________________________ 723
Chapter 132: Lymphomas _________________________________________________________ 724
Chapter 133: Ovarian Cancer _______________________________________________________ 726
Chapter 134: Acute Leukemias _____________________________________________________ 734
Chapter 135: Chronic Leukemias ____________________________________________________ 739
Chapter 136: Multiple Myeloma ____________________________________________________ 742
Chapter 137: Myelodysplastic Syndromes ____________________________________________ 746
Chapter 138: Renal Cell Carcinoma __________________________________________________ 751
, Chapter 139: Melanoma __________________________________________________________ 760
Chapter 140: Hematopoietic Stem Cell Transplantation _________________________________ 767
SECTION 18: NUTRITIONAL DISORDERS _________________________________________ 779
Chapter 141: Assessment Of Nutrition Status And Nutrition Requirements __________________ 779
Chapter 142: Parenteral Nutrition ___________________________________________________ 784
Chapter 143: Enteral Nutrition _____________________________________________________ 795
Chapter 144: Obesity _____________________________________________________________ 799
,SECTION 1: FOUNDATION ISSUES
Chapter 1: Health Literacy And Medication Use
Joseph DiPiro: Pharmacotherapy: A Pathophysiologic Approach 10th Edition| Tenth Edition
MULTIPLE CHOICE
1. What Time Will The Trough Blood Level Need To Be Drawn If The Nurse
Administers The Intravenous Medication Dose At 9:00 Am?
A. 6:30 Am
B. 8:30 Am
C. 9:30 Am
D. 11:30 Am
CORRECT ANS: B
Trough Blood Levels Measure The Lowest Blood Level Of Medicine And Are
Obtained Just Before The Dose Is Administered. In This Case, 6:30 Am Is
Too Early To Obtain The Blood Level. The Other Two Times Occur After The
Medication Is Administered.
A. 6:30 Am Is Too Early As It Is Well Before The Scheduled Dose.
C. 9:30 Am And D. 11:30 Am Are Both After The Dose Has Been
Administered, So They Are Not Appropriate Times For The Trough Blood
Level.
2. What Will The Nurse Expect The Health Care Providers Order To Be
When Starting An Older Adult Patient On Thyroid Hormone Replacement
Therapy?
A. Administering A Loading Dose Of The Drug
,B. Directions On How To Taper The Drug
C. A Dosage That Is One Third To One Half Of The Regular Dosage
D. A Dosage That Is Double The Regular Dosage
CORRECT ANS: C
To Prevent Toxicity, Dosages For New Medications In Older Adults Should
Be One Third To One Half The Amount Of A Standard Adult Dosage.
Loading Doses Of Drugs Could Cause Severe Toxicity. Tapering Off Is
Characteristic Of Discontinuation Of Medications And Is Not Appropriate
For This Situation. Older Adults Generally Need A Lower Medication Dosage
Than Younger Patients.
A. Administering A Loading Dose Could Cause Toxicity, Which Is Not
Recommended For Older Adults.
B. Directions On How To Taper The Drug Are Used For Discontinuation Of
Medication, Not For Initiation.
D. A Dosage That Is Double The Regular Dosage Would Be Dangerous,
Especially For Older Adults Who Have A Slower Metabolism.
Dif: Cognitive Level: Application Ref: P. 29 Obj: 3 Top: Nursing Process Step:
Implementation
Msc: Nclex Client Needs Category: Physiological Integrity
3. Which Drugs Cause Birth Defects?
A. Teratogens
B. Carcinogens
C. Metabolites
D. Placebos CORRECT ANS: A
Teratogens Are Drugs That Cause Birth Defects. Carcinogens Cause Cancer.
Metabolites Are The End Product Of Metabolism. Placebos Are Drugs That
Have No Pharmacologic Activity.
, B. Carcinogens Cause Cancer, Not Birth Defects.
C. Metabolites Are The Byproducts Of Metabolism, Not Drugs That Cause
Birth Defects.
D. Placebos Are Inactive Substances That Do Not Have Any Pharmacologic
Effects, Including Birth Defects.
4. Which Life-Threatening Illness May Occur As A Result Of Aspirin
(Salicylate) Administration During Viral Illness To Patients Younger Than
20 Years Of Age?
A. Anaphylactic Shock
B. Reyes Syndrome
C. Chickenpox
D. Influenza A
CORRECT ANS: B
Children Are Susceptible To Reyes Syndrome If They Ingest Aspirin At The
Time Of Or Shortly After A Viral Infection Of Chickenpox Or Influenza.
Anaphylactic Shock Is Caused By A Hypersensitivity Reaction. Chickenpox Is
The Result Of Being Infected With A Virus. Influenza A Is Caused By A
Pathogen.
A. Anaphylactic Shock Is An Allergic Reaction, Not A Consequence Of
Aspirin Use During A Viral Illness.
C. Chickenpox Is Caused By A Viral Infection But Is Not Related To Aspirin
Administration.
D. Influenza A Is Caused By A Virus, Not Directly By Aspirin Use.
5. Which Classification Of Medications Commonly Causes Allergic Reactions
In Children?
